SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ — Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. […]
SAN DIEGO, Aug. 20, 2026 /PRNewswire/ — The Shareholders Foundation, Inc. announces that a deadline is coming up on October 31, 2026, in the lawsuit that was filed for certain investors in Aardvark Therapeutics, Inc. […]
Expanded indication enables clinicians to detect sarcopenia risk from the same rapid SOZO scan, supporting earlier intervention in cancer care. CARLSBAD, Calif., Aug. 18, 2026 /PRNewswire/ — ImpediMed, a leader in the development and commercialization […]
Compound Solutions’ patented spermidine – Yüth® – anchors the cellular-renewal side of Lemme’s debut healthy-aging formula, working alongside clinically-studied NMN, Resveratrol and the Lutemax SkinGlo® blend. CARLSBAD, Calif., Aug. 13, 2026 /PRNewswire-PRWeb/ — Compound Solutions, […]
Multi-program deal with revenue potential of $100 million per target SAN DIEGO, Aug. 15, 2026 /PRNewswire/ — Aizen Therapeutics, an AI-native biotechnology company focused on building oral biologics, today announced a multi-program collaboration with a […]
San Diego-based biotech pioneer shortlisted for the Prix Galien – having shown tremendous potential to improve human health SAN DIEGO , Aug. 14, 2026 /PRNewswire/ — BioSapien, the pioneering biotech company, is delighted to announce […]
The leading wellness brand earns an honored place on the list for the fifth time in five years of eligibility SAN DIEGO, Aug. 14, 2026 /PRNewswire/ — Cymbiotika, the leading wellness brand known for its […]
— IND clearance for ATR 1072 and launch of Corventis Phase 1/2 trial in PRKAG2 syndrome — — Achieved second milestone payment under global cardiovascular collaboration with Bristol Myers Squibb — SAN DIEGO, Aug. 13, […]
Conference Call Today at 4:30 p.m. ET SAN DIEGO, Aug. 13, 2026 /PRNewswire/ — Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical therapeutic company, today announced financial results for fiscal first […]
SAN DIEGO, Aug. 13, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”) today reported financial results for the second quarter of 2026. The biopharmaceutical company has two programs in ongoing clinical […]
Oversubscribed round with proceeds to support continued clinical development SAN DIEGO, Aug. 12, 2026 /PRNewswire/ — Amplifica Holdings Group, Inc. (“Amplifica”), a privately held, clinical-stage biopharmaceutical company developing novel therapies for hair growth, today announced […]
Powered by RyboCypher™, its proprietary AI-assisted proteogenomics platform, RyboDyn introduces proteins science didn’t know existed—and reveals cYBX1, a cryptic isoform of the well-known cancer driver YBX1. SAN DIEGO, Aug. 12, 2026 /PRNewswire/ — RyboDyn, Inc. […]
TAIPEI and SAN DIEGO, Aug. 12, 2026 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). A multinational research team comprising investigators from Poland, Slovakia, […]
Adds ABS-1230, a clinical-stage, potential first-in-class precision therapy for KCNT1+ epilepsy Leverages Jazz development expertise and commercial strength in rare and severe epilepsies Transaction includes $820 million upfront payment DUBLIN and SAN DIEGO, Aug. 10, […]
The article explains how dry eye and allergies can cause similar symptoms while requiring different approaches to treatment. CARLSBAD, N.M., Aug. 7, 2026 /PRNewswire/ — Are your red, watery eyes caused by allergies or something […]
Initiation of study marks an important milestone in advancing Neurocrine’s obesity portfolio and investigational metabolic disease pipeline SAN DIEGO, Aug. 7, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a […]
? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ? ? Excluding China, total revenue grew 6% both as reported and in constant currency ? […]
In a split-face study, Ourself’s Advanced Regenerative Serum delivered greater improvement than a three-product stacked regimen across six of seven aesthetic parameters — while simplifying the routine to a single step and saving patients approximately […]
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — Blacksmith Medicines, Inc. (Blacksmith), a leading biopharmaceutical company dedicated to discovering and developing therapeutics that target metalloenzymes, today announced the publication of research in the Journal of Medicinal […]
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial […]
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery […]
New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrated roadmap spanning AI-driven patient stratification, human translational validation, biomarker development, and pharmaceutical partnering. SACRAMENTO, Calif., and SAN DIEGO, Calif., Aug. 4,… Click […]
Research study is open to participants worldwide to advance understanding of this ultra-rare cancer predisposition disorder and support future care guidelines, research, and treatment development SAN DIEGO, July 31, 2026 /PRNewswire/ — Today, the Bloom […]
Acquisition Expands Quasar’s Technology Organization and Adds Nitinol Design, Development, and Manufacturing Capabilities SAN DIEGO, July 31, 2026 /PRNewswire/ — Quasar Medical, a global contract development and manufacturing organization (CDMO) specializing in minimally invasive medical… […]
SAN DIEGO, July 30, 2026 /PRNewswire/ — Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 results Revenue of $1.16 […]
Total Second-Quarter 2026 Revenue Grew 39% Year-Over-Year to $959 Million INGREZZA® (valbenazine) 2026 Net Sales Guidance Raised to $2.825 to $2.875 Billion Acquisition of Soleno Therapeutics Completed in May 2026 SAN DIEGO, July 30, 2026 […]
SAN DIEGO, July 30, 2026 /PRNewswire/ — BRIJ Medical, Inc., a medical device company advancing surgical incision management through innovative wound closure technologies, today announced a new Breakthrough Technology designation with Premier, Inc. Premier offers […]
SAN DIEGO, July 30, 2026 /PRNewswire/ — Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized, autologous cell therapies, today announced that sasineprocel (ANPD001), its lead investigational product, for the treatment of… Click […]
Bringing Novel Titanium Integrated Surface Technology to the Proven Platform CARLSBAD, Calif., July 29, 2026 /PRNewswire/ — Spinal Elements®, a spine technology company known for developing innovative surgical solutions that prioritize clinical performance and surgical […]
Beta-site engagement begins as Pictor introduces an integrated 96-well workflow designed for scalable targeted protein analysis in research laboratories. CARLSBAD, Calif., July 27, 2026 /PRNewswire/ — Pictor Holdings Inc., a global targeted proteomic platform company, […]
Copyright © 2026 Biotech Networks, LLC
